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▲ Introduc3on	  




▲ Summary	  and	  conclusions	  
2	  
The megatrends 
▲ Relentless	  growth	  of	  compu;ng,	  storage	  and	  
communica;on	  technologies	  
▽ Inexpensive	  terminals	  providing	  ubiquitous	  services	  
▲ Biomedical	  science	  becoming	  more	  quan;ta;ve	  
▽ Societal	  need	  of	  beCer	  care	  at	  lower	  costs	  
▲ Big	  data	  issues	  fueling	  research	  and	  businesses	  
▽ Models,	  algorithms,	  architectures	  to	  tame	  data	  deluge	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The megatrends: IEEE Spectrum 
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Engineering Trends: 










The sensory interface 
▲ The	  More	  than	  Moore	  revolu;on:	  
▽ Low-­‐cost	  volume	  produc;on	  
▽ Direct	  interface	  to	  informa;on	  processing	  systems	  
[Courtesy:	  ST]	   [Courtesy:	  EPFL]	  6	  
What is health? 
State of complex physical, mental and social well-being 
and not merely the absence of disease or infirmity  
7	  
▲ Predic;ve	  medicine	  
▽ Predict	  diseases	  using	  “omics”	  technologies	  
▲ Par;cipa;ve	  medicine	  
▽ Share	  data	  and	  experiences	  using	  social	  media	  
▲ Personalized	  medicine	  
▽ Adapt	  diagnosis	  and	  therapy	  to	  individual	  
▲ Preven;ve	  medicine	  
▽ Quality	  of	  aging	  through	  nutri;on	  and	  lifestyle	  
New medical trends: the 4 Ps 












▲ Summary	  and	  conclusions	  
10	  
E-health: objectives 
▲ BeCering	  medicine	  by	  electronic	  means	  
▲ Bringing	  low-­‐cost	  medicine	  to	  the	  people	  
▲ Exploi;ng	  electronic	  well-­‐being	  as	  a	  lifestyle	  
▲ Opportuni;es:	  
▽ Synergy	  of	  integrated	  electronic	  and	  sensing	  
▽ PlaUorm-­‐based	  design	  of	  electro-­‐sensing	  systems	  
▽ Mobile	  telephony	  as	  backbone	  
11	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▲ Some	  molecular	  tests	  can	  be	  done	  in	  real	  ;me	  	  
▽ Eﬃcient	  and	  lower	  cost	  for	  rou;ne	  care	  
▽ Some	  diagnos;cs	  require	  mul;ple	  tests	  
	  
▲ Emergency	  situa;ons	  require	  real-­‐;me	  measures	  
▽ Pa;ent’s	  ﬂuids	  are	  oZen	  connected	  
▽ Local	  tests	  and	  remote	  diagnosis	  
Point of care 
Tele-medicine:  
Monitoring chronic patients 
▲ Non-­‐invasive	  monitors	  	  
▽ Heart	  rate,	  SpO2,	  blood	  pressure	  
▲ Invasive	  monitors:	  
▽ Metabolites:	  glucose,	  lactate,	  cholesterol	  







Prototype for human implant [EPFL] 
Muti-sensor for lab animals [EPFL] 
GLUCOSE SENSOR [SenseonicsTM ] 
Acetaminophen 
Tele-medicine 
Remote ultrasound diagnosis 
▲ Portable	  ultrasound	  head	  &	  processor	  
▽ Untrained	  operator	  acquires	  3D	  volumes	  
▽ Beamforming,	  compression	  and	  transmission	  
▽ Radiologist/Sonographer	  evaluates	  images	  remotely	  
	  
New	  2D	  probes	  for	  
3D	  image	  acquisi;on	  
New	  low-­‐power,	  low-­‐
cost	  hardware	  design	  
Image	  reconstruc;on,	  
rota;on	  &	  sec;oning	  
16	  
▲ 3D	  Ultrasound	  imaging	  requires	  supercompu;ng:	  
▽ TB/sec	  of	  bandwidth,	  GB	  of	  storage	  and	  TOP/sec	  
▲ Electronics	  should	  be	  conﬁned	  in	  small	  volume	  
▽ And	  directly	  integrated	  with	  the	  probe	  
▲ Wide	  space	  of	  applica;ons,	  modes	  and	  parameters	  
Challenges: 
Remote ultrasound diagnosis 
u  Drug dosage according to the individual 
pharmacokinetic profile 
Therapeutic Drug Monitoring (TDM) 
17	   J. Hiemke / European journal of clinical pharmacology 64.2 (2008): 159-166.  
Drug concentration in blood 
18	  
Smart drug administration 
▲ Policy	  design:	  
▽ Determine	  the	  sequence	  and	  dose	  of	  the	  drug	  
▲ Predic;ve	  models:	  
▽ Extract	  system	  state	  from	  external	  parameters	  
▲ Close-­‐loop	  models:	  
▽ Measure	  system	  state:	  drug	  concentra;on	  
▲ Objec;ve:	  
▽ Minimize	  drug	  dose/administra;on	  	  












▽ Electrical,	  mechanical,	  op;cal	  
▲ Fluidics	  and	  transducers	  
▽ Micro	  tubes,	  valves,	  pumps	  
▲ Data	  acquisi;on	  electronics	  





The platform and its components 
▲ Electro-­‐chemical	  	  sensors	  for	  families	  of	  
targets	  beneﬁt	  from	  modular	  integra;on	  
▽ Similar	  scalable	  geometries	  
▽ Diﬀerent	  molecular	  func;onaliza;on	  
▽ Diﬀerent	  I/V	  response	  










Platform design example 
Constraints 
▲  Compact 
▲  Biosensor array  
▲  pH control 
▲  Temperature 
control 
▲  IC integration 







Biosensor pH sensor 










C.Baj-Rossi,et al. Biomedical Circuits and Systems, IEEE Transactions on, vol.8, no. 5, 2014 
▲ Co-­‐design	  of	  electronics	  and	  sensing	  is	  key	  
▽ Achieve	  low-­‐power	  consump;on	  
▽ Achieve	  small	  footprint	  
▲ PlaUorm-­‐based	  design	  
▽ Modularity	  of	  design	  is	  key	  to	  reducing	  NREs	  
▲ Electronic	  technology	  can	  be	  extended	  upwards	  
▽ Monolithic	  integra;on	  




Monolithic and TSV-based integration 
[Schienle	  et	  al.,	  JSSC	  2004]	  
[Temiz	  et	  al.,	  Lab	  on	  Chip	  2012]	  
	  
Disposable biosensing layer: In molecular sensing applications, suit-
able surface preparation procedures are required on the active area.
Although CMOS integration is desirable for these applications,
surface chemistry steps may degrade the protection layers (such as the
layers protecting the wirebonds), and may damage the sensitive elec-
tronics. Moreover, even after intensive cleaning, it is usually difficult
to revert the sensor to the initial state. This limits the repeatability and
reliability of the measurements. Furthermore, especially in clinical diag-
nostic applications, it is preferred to use the disposable sensor to avoid
any possible cross-contamination. One solution is to dispose of the com-
plete system after each measurement. Using the active-electronic bio-
sensor only once can be acceptable for research purposes, but it will
not be very attractive in the market due to economic reasons, especially
for a 3D integrated chip stack. The other solution is to use the active
electronics repeatedly and substitute the used biosensing area with a
new one after each measurement. Therefore, in this Letter, we propose
a new system comprising vertically stacked electronics and a layer of
biosensing sites atop, which can be attached and detached in the field
[16]. Fig. 3 shows an illustration of the proposed 3D integrated lab-
on-a-chip.
analogue front-end (90nm–600nm)















Fig. 3 Illustration of 3D integrated biosensor with detachable and dispos-
able biosensing layer [16]
This approach combines the advantages of both active-electronic and
passive-electronic (disposable) biochips in one system. The top sensing
layer is temporarily attached to the analogue interface circuit through
vertical interconnections. These allow the fabrication of high density
multi-target arrays since they solve the horizontal signal routing
problem encountered in disposable biosensors. In addition, since the
interface electronics is in the direct neighbourhood of the array, weak
sensor-signals can be amplified while being minimally affected by the
parasitic effects, thus leading to considerable improvement in sensitivity
and signal integrity. Analogue outputs are converted to digital signals
through on-chip analogue-to-digital converters and processed by dedi-
cated digital electronics. Hence, the signal processing required to
solve complex algorithms for target identification can be accomplished
on the system. This technology also allows employing different
measurement techniques (cyclic voltammetry, impedance measurement
etc.) by simply replacing the top sensing layer and configuring the ana-
logue front-end accordingly.
In addition to the electrical improvements, the proposed system has
some potential advantages in terms of fabrication and packaging.
First, the fabrication process for the replaceable top biosensing layer
and the CMOS are completely decoupled; for example, we can use
non-CMOS compatible processes and materials for the sensors. This
eliminates some of the difficulties encountered in post-CMOS proces-
sing of integrated sensors. Moreover, temperature control is extremely
important for certain biosensing applications. In active-electronic bio-
sensors for example, the temperature may vary due to CMOS power con-
sumption. In the disposable layer approach, the temperature coupling
between the CMOS and the sensing part can be reduced to some
extent. Last but not least, protecting the wirebonds from the solutions
is a serious packaging problem in CMOS-based sensors. Since we
replace the wirebonds with the TSVs and protect the CMOS chip with
the silicon housing, the CMOS chip is not exposed to the liquids
any more.
To demonstrate the feasibility of the system, we are developing test
vehicles through standard microfabrication processes. In the first gener-
ation, which involves rigid micro-contacts, the interconnections are fab-
ricated by silicon etching and electroplating. First, the silicon is etched
by DRIE to form the vias. Then, the contact openings are fabricated
by KOH etching, where the via sidewalls are protected by a thermally-
grown oxide layer. Following the etching steps, the openings are filled
with Ni electroplating. The backside of the wafer is then etched by
DRIE to reach the electroplated micro-contacts and to have an
opening where the CMOS stack can fit inside. Fig. 4 shows the SEM
photos of the front-side of the wafer after the etching steps, and back-
side of the wafer after Ni electroplating and back-side silicon etching.
These types of rigid contacts, however, do not offer the spring function.
Therefore, electrical contact is not always guaranteed for all connections
owing to possible height differences. Also, rigid contacts may give an
erosion problem on the CMOS pads, which degrades the reusability of













Fig. 4 SEM photos of front-side of wafer after via and contact opening
etching steps (left), and back-side of wafer after Ni electroplating and Si
DRIE (right) [16]
Fig. 5 shows an illustration of the disposable biosensing layer with the
spring contacts. For many years, such contacts have been employed for
MEMS probe cards for IC testing [17, 18]. Recently, the feasibility of
the spring contacts in CMOS-biosensor integration has also been
demonstrated [19]. In our approach, we use special geometries which
enable us to pattern the contacts aligned to {111} crystal planes. A
very conformal Parylene deposition is employed to form the springs
and to close the openings. The electrical connections between the elec-
trodes and the contacts are achieved by sputtering a metal film through
the openings. The wafer backside is then etched by DRIE to form a
silicon frame for the CMOS chip placement. Finally, the springs are
released by maskless Parylene etching from the backside. Fig. 6
shows an SEM photo of the contacts after backside silicon etching














Fig. 5 Illustration of biosensing layer with spring contacts
Parylene
silicon 20 mm
Fig. 6 SEM photo of spring contacts (wafer backside) before anisotropic
Parylene etching to release springs
Finally, since the whole idea is based on the replacement of the
sensing chip on top of the electronics, the alignment accuracy is of
central importance. For a compact and low-cost biosensing system, the
placement technique should not employ any expensive tool and
should be done easily in the field. In this sense, we propose to use the
silicon frame for the mechanical alignment. Test structures are fabricated
to statistically analyse the alignment accuracy in manual pick and place-
ment of diced chips into the silicon frames [15]. Fig. 7 shows the histo-
gram for the maximum alignment error in either direction for each chip.
The measurements demonstrate that the average alignment error is
5.5 mm, which is small enough for the electrode dimensions we target.
Electronics Letters Dec. 2011 – Special Supplement: Semiconductors in Personalised Medicine doi: 10.1049/el.2011.2683 S23
[Temiz	  et	  al.,	  El	  LeCers	  2011]	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1st CVD growth 2nd CVD growth
CMOS-compatible nanostructuring 
I. Taurino, et al., Nano Letters, 2014
▲ Electrode	  nano-­‐structuring	  on	  top	  of	  CMOS	  
▽ Increases	  sensi;vity	  and	  lowers	  LOD	  
▽ Carbon	  structure	  growth	  at	  450°C	  in	  two	  steps	  
Outline 
▲ Introduc;on	  








▽ The	  system	  must	  perform	  its	  func;on	  in	  any	  condi;on	  
▲ Security:	  
▽ No	  medical	  informa;on	  leaking	  to	  other	  par;es	  
▽ No	  access	  from	  non-­‐authorized	  sources	  
▲ Safety:	  
▽ Under	  no	  condi;on	  the	  health-­‐device	  can	  be	  a	  threat	  
▽ Safety	  must	  be	  guaranteed	  for	  both	  pa;ent	  and	  operator	  
▲ Dependability:	  
▽ All	  devices	  must	  work	  long	  ;me	  in	  possibly	  harsh	  condi;on	  
▽ Graceful	  degrada;on	  mechanisms	  
(c) Giovanni De Micheli  
29	  
▲ Diagnos;c	  systems	  
▽ Accuracy,	  linearity,	  limit	  of	  detec;on	  
▲ Drug	  administra;on	  decision	  support	  systems	  
▽ Decisions	  based	  on	  acquired	  data	  must	  be	  correct	  
▽ Life-­‐cri;cal	  systems	  
Correctness 
W. You,et al. BioNanoScience, 2013 
▲ Verify	  that	  a	  therapeu;c	  protocol	  is	  
▽ Consistent	  
▽ Complete	  
▲ Verify	  that	  a	  drug	  administra;on	  control	  unit	  
is	  a	  correct	  implementa2on	  of	  the	  protocol	  
▽ Model	  checking	  
The verification problem 
30	  
Formal model of Imatinib protocol 
31	   A. Simalastar,et al. International Journal on Artificial Intelligence Tools, vol. 23, no. 3, 2014 
▲ Reason	  about	  proper;es	  in	  a	  formal	  way	  
▽ Check	  for	  invariants	  
▲ Synthesize	  op;mal	  control	  policies	  for	  drug	  
administra;on	  
▽ Sequence	  of	  (;me,	  dose)	  
▲ Golden	  model	  to	  verify	  hardware	  implementa;on	  
Advantages of formal models 
32	  
▲ Very	  few	  protocols	  have	  a	  formal	  descrip;on	  
▽ Corner	  cases	  are	  hazardous	  for	  pa;ents	  
▲ Personaliza;on	  of	  drug	  dosage	  is	  important	  
▽ But	  s;ll	  used	  in	  few	  cases	  
▲ Modeling	  human	  body	  reac;on	  is	  cri;cal	  









▲ Summary	  and	  conclusions	  
34	  
▲ E-­‐health	  is	  an	  unstoppable	  life-­‐changing	  trend	  
with	  unlimited	  possibili;es	  
▲ The	  market	  is	  ar;culated:	  
▽ Some	  areas	  are	  harder	  than	  others	  to	  penetrate	  
▽ Many	  problems	  are	  s;ll	  not	  well	  understood	  
▽ Ethics	  and	  regula;ons	  play	  a	  major	  role	  
▲ Exci;ng	  ﬁeld	  for	  researchers	  and	  developers	  
Summary: 
Opportunities and challenges 
35	  
Conclusions 
▲ New	  electronic	  health	  systems	  and	  services	  will	  be	  
enabled	  by	  advances	  in	  biology	  and	  medicine,	  
in	  combina;on	  with	  progress	  in	  electronics	  	  
▲ The	  ra;onaliza;on	  of	  health	  care	  will	  provide	  
advanced	  care	  to	  a	  broader	  audience	  at	  lower	  cost	  
▲ Human	  factors	  will	  s;ll	  be	  central	  to	  decisions	  in	  
medicine	  	  -­‐	  decision	  support	  will	  be	  automated	  
36	  
Thank you 
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Thank you 
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